Clinical Trial

The PROMISE Survey

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The PROMISE Survey was developed to systematically assess the real-world experiences, treatment preferences, side effects, and outcomes from both patients and physicians dealing with prolactinomas. The aim is to generate insights that can guide future clinical research and improve individualized care strategies.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2025-04-17; most recent amendment 2026-01-05.
Status change: Recruiting → Active, Not Recruiting 2026-01-05
Status change: Not Yet Recruiting → Recruiting 2025-06-16
Trial Details
NCT Number NCT06936813
Lead Sponsor University Hospital, Basel, Switzerland
Conditions Prolactinoma, Pituitary Tumor
Enrollment 530 participants
Start Date 2025-06-13
Primary Completion 2026-01-01 (estimated)
Study Completion 2026-03-30 (estimated)
Updated on ClinicalTrials.gov 2026-01-08